Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 101–200 of 777
The gut microbiome in autoimmunity: Sex matters
Gomez, A., Luckey, D., & Taneja, V. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.04.016 · Cited by 163
“t1:9 Prevotella and Akkermansia Low abundance associated with low mucin degradation potential and high T1D incidence NR [80]”
BackgroundAssociation between gut microbiota and bone health: Potential mechanisms and prospective
Chen, Y.-C., Greenbaum, J., Shen, H., & Deng, H.-W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00513 · Cited by 165
Dougal, K., de la Fuente, G., Harris, P. A., Girdwood, S. E., Pinloche, E., Geor, R. J., Nielsen, B. D., Schott, H. C., Elzinga, S., & Newbold, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087424 · Cited by 165
Gut microbiota, the pharmabiotics they produce and host health
Patterson, E., Cryan, J. F., Fitzgerald, G. F., Ross, R. P., Dinan, T. G., & Stanton, C. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665114001426 · Cited by 163
“While one study demonstrated that the stool of bio-breeding diabetesresistant rats contained higher relative abundances of Lactobacillus and Bifidobacterium, compared with biobreeding diabetes-prone rats((61)), others have reported that lactate-producing species such as Lactobacillus, Lactococcus and Bifidobacterium w…”
ResultIdentification of a Core Bacterial Community within the Large Intestine of the Horse
Dougal, K., de la Fuente, G., Harris, P. A., Girdwood, S. E., Pinloche, E., & Newbold, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077660 · Cited by 166
The gut microbiota and Type 1 Diabetes
Gülden, E., Wong, F. S., & Wen, L. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.013 · Cited by 166
“Butyrate has been shown to enhance the intestinal barrier by regulating the assembly of tight junctions [65] and is also crucial for sufficient mucin synthesis [17].”
BackgroundHagihara, M., Kuroki, Y., Ariyoshi, T., Higashi, S., Fukuda, K., Yamashita, R., Matsumoto, A., Mori, T., Mimura, K., Yamaguchi, N., et al. (2020) · iScience · doi:10.1016/j.isci.2019.100772 · Cited by 162
Leonard, M. M., Valitutti, F., Karathia, H., Pujolassos, M., Kenyon, V., Fanelli, B., Troisi, J., Subramanian, P., Camhi, S., Colucci, A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020322118 · Cited by 162
“Pathway analysis revealed only minimal changes in pathways in controls, including a decreased abundance in sulfur metabolism, for which an increase has been associated with T1D (62).”
BackgroundInflammation-associated microbiota in pediatric eosinophilic esophagitis
Benitez, A. J., Hoffmann, C., Muir, A. B., Dods, K. K., Spergel, J. M., Bushman, F. D., & Wang, M.-L. (2015) · Microbiome · doi:10.1186/s40168-015-0085-6 · Cited by 162
“The effect of diet upon gut microbial composition has been explored previously in obesity [10-13] and inflammatory bowel disease (IBD) [10,14].”
BackgroundMicrobial antigen mimics activate diabetogenic CD8 T cells in NOD mice
Tai, N., Peng, J., Liu, F., Gulden, E., Hu, Y., Zhang, X., Chen, L., Wong, F. S., & Wen, L. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160526 · Cited by 161
“Most interestingly, a newly published study used a human CD8 + T cell clone (1E6), which is MHC class I restricted and human prepro-insulin reactive, to generate high-resolution structures of the 1E6 TCR bound to seven altered peptide ligands, including a microbe-derived peptide (Cole et al., 2016).”
BackgroundThe gut microbiome of nonhuman primates: Lessons in ecology and evolution
Clayton, J. B., Gomez, A., Amato, K., Knights, D., Travis, D. A., Blekhman, R., Knight, R., Leigh, S., Stumpf, R., Wolf, T., et al. (2018) · American Journal of Primatology · doi:10.1002/ajp.22867 · Cited by 162
Functional assignment of metagenomic data: challenges and applications
Prakash, T., & Taylor, T. D. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs033 · Cited by 166
“In another study, the gut metagenomes of four healthy individuals were compared to those of individuals with autoimmune disorders, including type I diabetes [98].”
BackgroundThe gut microbiome and elevated cardiovascular risk in obesity and autoimmunity
Kasselman, L. J., Vernice, N. A., DeLeon, J., & Reiss, A. B. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.036 · Cited by 161
Clinical implications of shared genetics and pathogenesis in autoimmune diseases
Zhernakova, A., Withoff, S., & Wijmenga, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.161 · Cited by 158
Gut microbiota and Hashimoto’s thyroiditis
Virili, C., Fallahi, P., Antonelli, A., Benvenga, S., & Centanni, M. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9467-y · Cited by 182
Valladares, R., Bojilova, L., Potts, A. H., Cameron, E., Gardner, C., Lorca, G., & Gonzalez, C. F. (2013) · The FASEB Journal · doi:10.1096/fj.12-223339 · Cited by 158
“ring during inflammatory responses (9, 11, 32).”
Kanbay, M., Onal, E. M., Afşar, B., Dağel, T., Yerlikaya, A., Covic, A. C., & Vaziri, N. D. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1873-2 · Cited by 162
“Interestingly, the abundance of many microbial genera related to the gut mucosal barrier function is changed in these diseases such that Lactobacilli, Bifidobacteria, Pseudobutyrivibrio, Roseburia, and Faecalibacterium are reduced while Clostridium perfringens , Bacteroides spp., Prevotella, Betaproteobacteria, and De…”
BackgroundInfluentialPellegrini, S., Sordi, V., Bolla, A. M., Saita, D., Ferrarese, R., Canducci, F., Clementi, M., Invernizzi, F., Mariani, A., Bonfanti, R., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3222 · Cited by 152
“producing and mucin-degrading bacteria, with immunomodulating properties, and are generally associated with a balanced status of gut mucosa; the reduction in Clostridia that we observed in patients with T1D agrees with other studies where similar findings were described (even if on fecal samples) (11, 14), and it coul…”
ResultProbiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 151
“Since SIBO is prevalent in PD [78], and motor dysfunction is worse in these patients positive for SIBO [112], synbiotics have a potential to be considered for PD.”
BackgroundMethodThe Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 152
The impact of diabetes on corneal nerve morphology and ocular surface integrity
Markoulli, M. P., Flanagan, J., Tummanapalli, S. S., Wu, J., & Willcox, M. D. P. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.10.006 · Cited by 169
Dark matter in host-microbiome metabolomics: Tackling the unknowns–A review
Peisl, B. Y. L., Schymanski, E. L., & Wilmes, P. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.12.034 · Cited by 146
Dolpady, J., Sorini, C., Di Pietro, C., Cosorich, I., Ferrarese, R., Saita, D., Clementi, M., Canducci, F., & Falcone, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/7569431 · Cited by 145
“In humans, T1D susceptibility has been linked to compositional changes in the gut microbiota and, specifically, with a significant increased representation of bacteria of the Bacteroidetes phylum and a decrease in the number of Bifidobacterium, Lactobacillus, and Clostridium strains [3] [4] [5].”
BackgroundSantiago-Rodríguez, T. M., & Hollister, E. B. (2019) · Viruses · doi:10.3390/v11070656 · Cited by 160
“Specifically, Prevotella, Faecalibacterium, Eubacterium, Fusobacterium, Anaerostipes, Roseburia and Subdoligranulum have been described as being more abundant in healthy controls compared to T1D subjects [103].”
Interactions between dietary flavonoids and the gut microbiome: a comprehensive review
Baky, M. H., Elshahed, M., Wessjohann, L., & Farag, M. A. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003627 · Cited by 135
“one of the most abundant short chain fatty acid (SCFA) producing bacteria (42) .”
BackgroundDifferences in the gut microbiota of healthy children and those with type 1 diabetes
Soyucen, E., Gulcan, A., Aktuglu‐Zeybek, A. C., Onal, H., Kiykim, E., & Aydin, A. (2014) · Pediatrics International · doi:10.1111/ped.12243 · Cited by 144
Li, G., Yang, M., Zhou, K., Zhang, L., Tian, L., Lv, S., Jin, Y., Qian, W., Xiong, H., Lin, R., et al. (2015) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1412.12047 · Cited by 140
“Certain bacteria have been found to be associated with diseases such as inflammatory bowel disease [14], irritable bowel syndrome (IBS) [7], colorectal carcinoma [32], and even systemic diseases such as diabetes [5], obesity [24], and psychological disorders [6].”
BackgroundLuo, J., & Long, Y. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2883041 · Cited by 150
“[13], diabetes [14], [15], obsity [16], [17], allergic asthma [18],”
BackgroundLeonard, M. M., Karathia, H., Pujolassos, M., Troisi, J., Valitutti, F., Subramanian, P., Camhi, S. S., Kenyon, V., Colucci, A., Serena, G., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00906-w · Cited by 157
“Of note, defects in folate biosynthesis have been linked to an impaired immune response to viral infections and reduced natural killer cell response possibly contributing to T1D onset [42].”
InfluentialHarbison, J. E., Roth‐Schulze, A. J., Giles, L. C., Tran, C. D., Ngui, K., Penno, M. A. S., Thomson, R. L., Wentworth, J. M., Colman, P. G., Craig, M. E., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12865 · Cited by 162
“5 (6-24) 13 (2-34) Stool samples per individual 2 (1-6) 3 (1-6) 1.”
BackgroundCurrent understandings of the pathogenesis of type 1 diabetes: genetics to environment
Giwa, A. M., Ahmed, R., Omidian, Z., Majety, N., Karakus, K. E., Omer, S. M., Donner, T., & Hamad, A. R. A. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.13 · Cited by 137
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health
Ha, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16498 · Cited by 137
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 128
“A metagenomic study suggests that a consortium of lactate- and butyrate-producing gut bacteria can induce a sufficient amount of mucin synthesis to maintain gut integrity and prevent the development of autoimmune diseases including type 1 diabetes [53].”
BackgroundAlteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing
Chen, X., Sun, H., Jiang, F., Shen, Y., Li, X., Hu, X., Shen, X., & Wei, P. (2020) · PeerJ · doi:10.7717/peerj.8317 · Cited by 133
“However, these short-chain fatty acids cannot synthesize mucoprotein but can lead to the increased permeability of intestinal mucosa and facilitate the formation of inflammation (Brown et al., 2011).”
BackgroundFugmann, M., Breier, M., Rottenkolber, M., Banning, F., Ferrari, U., Sacco, V., Grallert, H., Parhofer, K. G., Seissler, J., Clavel, T., et al. (2015) · Scientific Reports · doi:10.1038/srep13212 · Cited by 131
Masetti, G., Moshkelgosha, S., Köhling, H.-L., Covelli, D., Banga, J. P., Berchner‐Pfannschmidt, U., Horstmann, M., Díaz‐Cano, S. J., Goertz, G.-E., Plummer, S. F., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0478-4 · Cited by 138
“71 Over the years the gut microbiota has been associated with several diseases [14-17] and its 72 confounding role in establishing or reproducing disease phenotype in murine models has also 73 been proposed [18].”
Breastfeeding and autoimmunity: Programing health from the beginning
Borba, V. V., Sharif, Κ., & Shoenfeld, Y. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12778 · Cited by 155
Harmsen, H. J. M., & de Goffau, M. C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-31248-4_7 · Cited by 160
The intestinal microbiome in type 1 diabetes
Dunne, J. L., Triplett, E. W., Gevers, D., Xavier, R., Insel, R., Danska, J., & Atkinson, M. A. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12321 · Cited by 126
Self-citationPark, H.-J., Lee, S.-E., Kim, H.-B., Isaacson, R. E., Seo, K.-W., & Song, K.-H. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12455 · Cited by 123
“ance, principal component analysis plots (PCA) were generated using the function prcomp in the R package.(30) 44 Park et al”
MethodPérez‐Santiago, J., Gianella, S., Massanella, M., Spina, C. A., Karris, M., Var, S. R., Patel, D. R., Jordan, P. S., Young, J. A., Little, S. J., et al. (2013) · AIDS · doi:10.1097/qad.0b013e3283611816 · Cited by 143
“NGS of the gut microbiome has revealed that certain disease states, such as inflammatory bowel disease, HIV, and others may be associated with modified gut flora [15–17].”
BackgroundA model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes
Davis-Richardson, A. G., & Triplett, E. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3614-8 · Cited by 122
“Bacterial functions associated with disease have been listed for a very small cohort from the DIPP study [16].”
BackgroundInfluentialSelf-citationZhou, H., Sun, L., Zhang, S., Zhao, X. Y., Gang, X., & Wang, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00125 · Cited by 146
“Conversely, these bacteria would reduce the assembly of TJ and generate an increase in gut permeability, eventually promoting the T1D-associated autoimmunity (27, 150).”
BackgroundInfluentialDiet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution
Mejía-León, M., & Barca, A. (2015) · Nutrients · doi:10.3390/nu7115461 · Cited by 125
“To explain the pathways and the impact of T1D‐associated dysbiosis in the metabolism, it is necessary to study the microbiota structural dynamics as an integral organ [52].”
BackgroundInfluentialVildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
Zhang, Q., Xiao, X., Li, M., Yu, M., Ping, F., Zheng, J., Wang, T., & Wang, X. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184735 · Cited by 124
Tuohy, K. M., Fava, F., & Viola, R. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003911 · Cited by 125
Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells
Sen, P., Kemppainen, E., & Orešič, M. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00096 · Cited by 125
“It has been demonstrated that composition of the gut microbiota may be altered in individuals at risk of developing T1DM (Brown et al., 2011; Giongo et al., 2011; de Goffau et al., 2013; Murri et al., 2013).”
BackgroundPathophysiology of Type 1 Diabetes and Gut Microbiota Role
CHIERICO, F. D., Rapini, N., Deodati, A., Matteoli, M. C., Cianfarani, S., & Putignani, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314650 · Cited by 146
Short-chain fatty acids and gut microbiota in multiple sclerosis
Melbye, P., Olsson, A., Hansen, T. H., Søndergaard, H. B., & Oturai, A. B. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.13045 · Cited by 134
Short chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 133
Yan, X., Yang, C., Lin, G., Chen, Y., Miao, S., Liu, B., & Zhao, C. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14415 · Cited by 129
Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease
Douglas, G. M., Hansen, R., Jones, C. M. A., Dunn, K. A., Comeau, A., Bielawski, J. P., Tayler, R., El-Omar, E. M., Russell, R. K., Hold, G. L., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0398-3 · Cited by 131
“The genus Alistipes is a known producer of short-chain fatty acids (SCFAs) [54].”
BackgroundAdvances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
Cayabyab, F., Nih, L. R., & Yoshihara, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732431 · Cited by 135
Relationship between gut microbiota and development of T cell associated disease
Kosiewicz, M. M., Dryden, G. W., Chhabra, A., & Alard, P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.019 · Cited by 117
“In a second study, the same group found that butyrate-producing bacteria are decreased in the seropositive children [100].”
BackgroundThe Role of the Gut Microbiome on Chronic Kidney Disease
Sampaio‐Maia, B., Simões‐Silva, L., Pestana, M., Araújo, R., & Soares‐Silva, I. (2016) · Advances in applied microbiology · doi:10.1016/bs.aambs.2016.06.002 · Cited by 135
A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development
Hill, J. H., Franzosa, E. A., Huttenhower, C., & Guillemin, K. J. (2016) · eLife · doi:10.7554/elife.20145 · Cited by 133
Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis
Bullich, C., Keshavarzian, A., Garssen, J., Kraneveld, A., & Perez‐Pardo, P. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12840 · Cited by 114
“of these bacteria may reveal a lower mucin synthesis in the colonic mucosal layers, which is related to higher mucosal permeability.(88)”
Backgroundde Groot, P. F., Nikolić, T., Imangaliyev, S., Bekkering, S., Duinkerken, G., Keij, F. M., Herrema, H., Winkelmeijer, M., Kroon, J., Levin, E., et al. (2020) · Diabetologia · doi:10.1007/s00125-019-05073-8 · Cited by 122
O’Donnell, S. T., Ross, R. P., & Stanton, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03084 · Cited by 129
“This information allows correlation-based work to compare the abundance of particular gene families to the respective environment (Brown et al., 2011).”
BackgroundMencarelli, A., Cipriani, S., Renga, B., Bruno, A., D'Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 116
“Thus, while metagenomic studies are progressively deciphering the role of bacterial genes and proteins in the regulation of host’s metabolism, specific bacterial enterotypes have been associated to the development of human diseases such as diabetes and obesity [43–47].”
BackgroundKrych, Ł., Nielsen, D., Hansen, A., & Hansen, C. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1011876 · Cited by 114
Gholizadeh, P., Mahallei, M., Pormohammad, A., Varshochi, M., Ganbarov, K., Zeinalzadeh, E., Yousefi, B., Bastami, M., Tanomand, A., Mahmood, S. S., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.11.031 · Cited by 124
Kemppainen, K. M., Ardissone, A. N., Davis-Richardson, A. G., Fagen, J. R., Gano, K. A., León-Novelo, L. G., Vehik, K., Casella, G., Simell, O., Ziegler, A. G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-0850 · Cited by 112
Self-citationMaffeis, C., Martina, A., Corradi, M., Quarella, S., Nori, N., Torriani, S., Plebani, M., Contreas, G., & Felis, G. E. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2790 · Cited by 110
“Interestingly, the microorganisms we detected support the functional model suggested in the literature [15] because the main products of their metabolism are short”
BackgroundInfluentialChang, B., Sang, L., wang, Y., Tong, J., Zhang, D., & Wang, B. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-151 · Cited by 106
Marcial, G. E., Ford, A. L., Haller, M. J., Gezan, S. A., Harrison, N. A., Cai, D., Meyer, J. L., Perry, D. J., Atkinson, M. A., Wasserfall, C. H., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00655 · Cited by 104
“These studies have shown a low abundance of lactate-producing and butyrate-producing species and an increase of the Bacteroides genus in children with autoimmunity when compared to controls (10, 11).”
BackgroundSelf-citationWade, H., Pan, K., Duan, Q., Kaluzny, S., Pandey, E., Fatumoju, L., Saraswathi, V., Wu, R., Harris, E. N., & Su, Q. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00935-1 · Cited by 121
Endesfelder, D., Engel, M., Davis-Richardson, A. G., Ardissone, A. N., Achenbach, P., Hummel, S., Winkler, C., Atkinson, M., Schatz, D., Triplett, E., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0163-4 · Cited by 106
“However, although several researchers analyzed the gut microbiome after autoantibody development [14, 16, 19] or T1D onset [20, 21], few studies focus on the period prior to autoantibody development [15, 17, 18].”
Self-citationShen, H., Gao, X., Li, T., Jing, W., Han, B.-L., Jia, Y., Hu, N., Yan, Z., Li, S., & Yan, R. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.01.021 · Cited by 109
Type 1 diabetes: role of intestinal microbiome in humans and mice
Boerner, B. P., & Sarvetnick, N. E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06340.x · Cited by 107
Is there a role for gut microbiota in type 1 diabetes pathogenesis?
Bibbò, S., Dore, M. P., Pes, G. M., Delitala, G., & Delitala, A. P. (2017) · Annals of Medicine · doi:10.1080/07853890.2016.1222449 · Cited by 108
“Similar alterations in gut microbiota were reported in children with newly diagnosed T1D (59,60).”
BackgroundResultJia, L., Shan, K., Pan, L.-L., Feng, N., Lv, Z., Sun, Y., Li, J., Wu, C., Zhang, H., Chen, W., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01345 · Cited by 107
“Healthy children have a higher proportion of butyrateproducing bacteria in their microbiomes compared with children expressing at least one beta islet cell autoantibody (7, 8).”
BackgroundHuman milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice
Xiao, L., Land, B. V., Engen, P. A., Naqib, A. D., Green, S. J., Nato, A., Leusink-Muis, T., Garssen, J., Keshavarzian, A., Stahl, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22052-y · Cited by 117
Co-occurrence of Type 1 Diabetes and Celiac Disease Autoimmunity
Hagopian, W., Lee, H. S., Liu, E., Rewers, M., She, J., Ziegler, A., Lernmark, Å., Toppari, J., Rich, S. S., Krischer, J. P., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1305 · Cited by 119
Khan, A., Gani, A., Khanday, F., & Masoodi, F. (2017) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2017.12.002 · Cited by 84
Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Chiang, H.-L., & Lin, C.-H. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 104
Nuzum, N. D., Loughman, A., Szymlek-Gay, E. A., Hendy, A., Teo, W.-P., & Macpherson, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.003 · Cited by 103
Faecal microbiome in new-onset juvenile idiopathic arthritis
Tejesvi, M. V., Arvonen, M., Kangas, S. M., Keskitalo, P. L., Pirttilä, A. M., Karttunen, T. J., & Vähäsalo, P. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2548-x · Cited by 114
“There is emerging data that support the presence of intestinal microbial alterations in the pathogenesis of autoimmune disorders, such as inflammatory bowel disease, type 1 diabetes mellitus and rheumatoid arthritis [1–4].”
BackgroundResultEmerging role of gut microbiota in autoimmune diseases
Wang, X., Yuan, W., Yang, C., Wang, Z., Zhang, J., Xu, D., Sun, X., & Sun, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1365554 · Cited by 132
Is there any association between gut microbiota and type 1 diabetes? A systematic review
Jamshidi, P. K., Hasanzadeh, S., Tahvildari, A., Farsi, Y., Arbabi, M., Mota, J. F., Sechi, L. A., & Nasiri, M. J. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0332-7 · Cited by 109
Estrogen, estrogen-like molecules and autoimmune diseases
Merrheim, J., Villegas, J. A., Wassenhove, J. V., Khansa, R., Berrih‐Aknin, S., Panse, R. L., & Dragin, N. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102468 · Cited by 110
A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes
Chia, J. S., McRae, J. L., Kukuljan, S., Woodford, K. B., Elliott, R. B., Swinburn, B. A., & Dwyer, K. M. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2017.16 · Cited by 118
PBHMDA: Path-Based Human Microbe-Disease Association Prediction
Huang, Z.-A., Chen, X., Zhu, Z., Liu, H., Yan, G., You, Z., & Wen, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00233 · Cited by 101
“For examples, Brown et al. (2011) discovered that, the autoimmune subjects could be participated in triggering a type 1 diabetes associated autoimmune response.”
BackgroundModulation of Type 1 Diabetes Risk by the Intestinal Microbiome
Knip, M., & Honkanen, J. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0933-9 · Cited by 110
Self-citationA Maternal Gluten-Free Diet Reduces Inflammation and Diabetes Incidence in the Offspring of NOD Mice
Hansen, C. H. F., Krych, Ł., Buschard, K., Metzdorff, S. B., Nellemann, C., Hansen, L. H., Nielsen, D. S., Frøkiær, H., Skov, S., & Hansen, A. K. (2014) · Diabetes · doi:10.2337/db13-1612 · Cited by 107
“In addition, taxonomic differences between the gut microbiomes of healthy and diabetic children were characterized by mucin-degrading Akkermansia, which was more abundant in control subjects than in case patients (33).”
BackgroundRole of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
Sohail, M. U., Althani, A., Anwar, H., Rizzi, R., & Marei, H. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9631435 · Cited by 99
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 114
“In type 1 DM, by contrast, mucin synthesis was inhibited by non-butyrate-producing lactate-utilizing bacteria, a condition that contributes to the autoimmunity of β -cells and type [305].”
An Insight Into the Intestinal Web of Mucosal Immunity, Microbiota, and Diet in Inflammation
Yap, Y. A., & Mariño, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02617 · Cited by 108
“This is in contrast with other SCFA producers such as Bacteroides and Alistipes, which were more abundant in the feces of diabetic individuals (15).”
BackgroundResultInfluentialRoslund, M. I., Puhakka, R., Nurminen, N., Oikarinen, S., Siter, N., Grönroos, M., Cinek, O., Kramná, L., Jumpponen, A., Laitinen, O. H., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106811 · Cited by 93
Self-citationLin, X. B., Farhangfar, A., Valcheva, R., Sawyer, M. B., Dieleman, L., Schieber, A., Gänzle, M. G., & Baracos, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083644 · Cited by 96
“A reduction in butyryl-CoA transferase gene was reported for colorectal cancer [6] and Type I diabetes [41] and was considered a reflection of dysbiosis.”
BackgroundLiu, H., Pan, L., Lv, S., Yang, Q., Zhang, H., Chen, W., Lv, Z., & Sun, J. T. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01015 · Cited by 115
“As mucin degrading bacteria, Prevotella may contribute to increased gut permeability (Brown et al., 2011).”
BackgroundThe emerging role of the small intestinal microbiota in human health and disease
Ruigrok, R. A. A. A., Weersma, R. K., & Vich Vila, A. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201155 · Cited by 91
“Clostridia contribute significantly to butyrate production in the gut and are also key mucin-degrading bacteria, both of which are important for barrier integrity and possibly preventing autoantibody formation.(146,147) Segmented filamentous bacterial strains in non-obese diabetic mice were also shown to induce autoim…”
BackgroundMicrobiota and Autoimmunity: Exploring New Avenues
Yurkovetskiy, L. A., Pickard, J. M., & Chervonsky, A. V. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.010 · Cited by 94
“However, the cohorts analyzed were relatively small [between 8 and 36 subjects including healthy controls (Brown et al., 2011, de Goffua et al., 2013, Kostic et al., 2015)].”
BackgroundPenno, M. A. S., Couper, J., Craig, M. E., Colman, P. G., Rawlinson, W. D., Cotterill, A. M., Jones, T. W., Harrison, L. C., & ENDIA Study Group (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-124 · Cited by 103
“Two small European studies involving a total of 17 children with islet autoimmunity and 17 age/gender/HLA genotype matched controls reported decreased microbial diversity in stools from children with islet autoimmunity [33,34], while metagenomic analysis revealed that children with islet autoimmunity have less butyrat…”
Helicobacter pylori infection is associated with an altered gastric microbiota in children
Brawner, K. M., Kumar, R., Serrano, C. A., Ptacek, T., Lefkowitz, E. J., Morrow, C. D., Zhi, D., Kyanam-Kabir-Baig, K., Smythies, L. E., Harris, P. R., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.131 · Cited by 100
Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease
Jiang, W., Yu, X., Kosik, R. O., Song, Y., Qiao, T., Tong, J., Liu, S., Fan, S., Luo, Q., Chai, L., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0193 · Cited by 105
“This leads to reduced intestinal tight junctions and increased permeability of the intestinal mucosa (22).”
BackgroundDiversified gut microbiota in newborns of mothers with gestational diabetes mellitus
Su, M., Nie, Y., Shao, R., Duan, S., Jiang, Y., Wang, M., Xing, Z., Sun, Q., Liu, X., & Xu, W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205695 · Cited by 103
Gut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
“Functional comparison between the gut microbiota of T1D cohorts and controls reveals higher expression levels of genes involved in adhesion and flagellum synthesis and underrepresentation of butyrate‐producing bacteria in cases that most likely underlie an inappropriate autoimmune response.(111) Other studies have hig…”
The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus
Crăciun, C.-I., Neag, M. A., Cătinean, A., Mitre, A. O., Rusu, A., Bala, C. G., Román, G., Buzoianu, A. D., Muntean, D. M., & Craciun, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10020308 · Cited by 105
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
Pagliari, D., Saviano, A., Newton, E. E., Serricchio, M. L., Dal Lago, A. A., Gasbarrini, A., & Cianci, R. (2018) · Mediators of Inflammation · doi:10.1155/2018/7946431 · Cited by 89
“Other butyrate-producing and mucin-degrading bacteria, such as Prevotella and Akkermansia muciniphila, are decreased [89] while short-chain fatty acid- (SCFAs-) producing bacteria such as Klebsiella are increased.”
Background
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.